Kobe Based Biomedical Research Center Receives ¥10 Billion Funding From UAE Government Fund
This article was originally published in PharmAsia News
Koichi Tanaka, Director of Kobe-based Biomedical Research Center, which gained worldwide recognition for conducting a liver transplant utilizing a living donor, announced on June 13 that the center is expected to receive ¥10 billion in funding from a government fund of the United Arab Emirates. The fund will be used to build Kobe International Frontier Medical Center that focus on transplant medical and regenerative medicine research. Tanaka has also been raising funds from pharmaceutical companies. The Abu Dhabi government is believed to use oil money to invest in next generation biomedical research and technological development. (Click here for more - Japanese language
You may also be interested in...
Deputy CEO Nicolas Hieronimus will take L’Oreal’s helm beginning in May 2021, with Jean-Paul Agon continuing as chairman, the firm announced on 14 October. The Estee Lauder Companies hires PepsiCo’s Gibu Thomas to lead its online business, and Coty appoints its first chief digital officer.
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.